ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

39,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 6645

$3.14M Total Retail Price of All Prescriptions

Rank: 30 out of 6645

906 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 906 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 37,337 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,410 1,319 1 2
OMEPRAZOLE 1,385 1,309 2 6
CELEBREX 1,139 1,092 3 54
SIMVASTATIN 1,045 950 4 1
LIDODERM 910 878 5 53
DONEPEZIL HCL 908 901 6 27
NEXIUM 856 782 7 40
MELOXICAM 850 796 8 46
TAMSULOSIN HCL 783 754 9 22
EVISTA 718 701 10 90
ZOLPIDEM TARTRATE 716 682 11 17
GLYBURIDE-METFORMIN HCL 665 614 R 12 95
NAMENDA 643 642 13 41
CREON 612 602 14 114
DIOVAN HCT 599 565 15 64
METFORMIN HCL 570 536 16 7
ATORVASTATIN CALCIUM 549 516 17 10
AZITHROMYCIN 531 482 18 44
DIOVAN 509 461 19 19
GABAPENTIN 504 476 20 18
ALENDRONATE SODIUM 491 459 21 14
ATENOLOL 483 472 22 8
LEVOTHYROXINE SODIUM 466 434 23 4
CLOPIDOGREL 427 413 24 36
ACETAMINOPHEN-CODEINE 412 384 S3 25 80
LOSARTAN-HYDROCHLOROTHIAZIDE 392 389 26 62
BACLOFEN 371 344 27 100
AMLODIPINE BESYLATE-BENAZEPRIL 362 330 28 97
AVODART 334 322 29 99
CRESTOR 333 298 30 34
TRIAMCINOLONE ACETONIDE 313 295 31 55
GLIMEPIRIDE 306 302 32 47
HYDROCODONE-ACETAMINOPHEN 306 289 S3 32 5
BENAZEPRIL HCL 300 237 34 21
LEVOFLOXACIN 297 273 35 83
ISOSORBIDE MONONITRATE ER 297 295 35 66
PLAVIX 293 281 37 49
SINGULAIR 291 288 38 76
ACTONEL 282 274 39 92
LOSARTAN POTASSIUM 268 265 40 12
FUROSEMIDE 264 257 41 11
LEVOCETIRIZINE DIHYDROCHLORIDE 253 234 42 241
IBANDRONATE SODIUM 246 235 43 147
LOVAZA 243 231 44 68
TRAMADOL HCL 242 228 45 30
METOPROLOL SUCCINATE 240 238 46 24
VOLTAREN 237 233 47 108
DEXILANT 233 213 48 102
IBUPROFEN 230 200 49 42
MEGESTROL ACETATE 224 223 R 50 104
BENICAR 222 218 51 84
CARVEDILOL 219 204 52 25
JANUVIA 202 202 53 38
MONTELUKAST SODIUM 195 187 54 128
CLOTRIMAZOLE-BETAMETHASONE 191 182 55 177
ACTOS 190 183 56 71
PROPRANOLOL HCL 187 179 57 151
PATANOL 187 171 57 131
METOPROLOL TARTRATE 186 154 59 13
QUETIAPINE FUMARATE 186 175 59 101
PREDNISONE 177 168 61 57
METRONIDAZOLE 173 158 62 329
FAMOTIDINE 169 165 63 33
VESICARE 165 148 64 148
LYRICA 165 149 64 127
EXFORGE 159 159 66 155
HYDROCHLOROTHIAZIDE 154 142 67 9
FENOFIBRATE 152 125 68 74
CIPROFLOXACIN HCL 149 142 69 67
LISINOPRIL 139 117 70 3
SERTRALINE HCL 132 130 71 43
LANTUS SOLOSTAR 132 127 71 139
PANTOPRAZOLE SODIUM 132 131 71 29
AZOR 130 130 74 152
NIFEDIPINE ER 129 129 75 82
CYMBALTA 128 110 76 78
DESMOPRESSIN ACETATE 127 127 77 480
LIPITOR 125 123 78 69
CEPHALEXIN 122 112 79 111
METOCLOPRAMIDE HCL 122 118 79 120
ACIPHEX 120 120 81 167
ACTOPLUS MET 115 104 82 275
PEN NEEDLE 114 113 83 159
BENICAR HCT 114 112 83 158
BONIVA 112 111 85 191
WARFARIN SODIUM 111 108 86 16
FORTEO 108 108 87 280
VALSARTAN-HYDROCHLOROTHIAZIDE 107 100 88 314
POTASSIUM CHLORIDE 107 107 88 28
TERBINAFINE HCL 105 89 90 471
ECONAZOLE NITRATE 103 94 91 263
MICARDIS HCT 100 100 92 299
VIAGRA 97 81 93 335
OXYBUTYNIN CHLORIDE 96 94 94 129
PROCTOZONE-HC 94 88 95 243
SEROQUEL 93 86 96 208
BYSTOLIC 93 93 96 110
SUCRALFATE 92 82 98 256
GLYBURIDE 91 88 R 99 58
ZENPEP 91 84 99 210
JANUMET 90 90 101 132
ADVAIR DISKUS 90 90 101 45
EXELON 89 88 103 149
DOXAZOSIN MESYLATE 85 85 104 81
PREMARIN 84 84 R 105 169
DIVALPROEX SODIUM 80 78 106 113
ROPINIROLE HCL 80 78 106 166
CLONIDINE HCL 79 68 108 56
ZETIA 79 79 108 87
NITROFURANTOIN MONO-MACRO 78 75 110 233
NASONEX 77 74 111 126
LANSOPRAZOLE 73 72 112 163
RESTASIS 69 68 113 311
PRISTIQ ER 69 69 113 474
DICYCLOMINE HCL 69 66 113 278
LANTUS 67 63 116 50
SODIUM CHLORIDE 67 67 116 216
CIALIS 67 66 116 419
PIOGLITAZONE HCL 66 65 R 119 184
ONGLYZA 66 61 119 168
AMOXICILLIN 66 55 119 107
DIGOXIN 65 65 122 59
PREMPRO 65 59 R 122 369
ENALAPRIL MALEATE 65 65 122 75
PAROXETINE HCL 64 64 125 72
FINASTERIDE 63 63 126 73
NOVOLIN R 63 63 126 142
ALBUTEROL SULFATE 63 60 126 112
LEVETIRACETAM 63 60 126 119
GEMFIBROZIL 61 53 130 96
CARBIDOPA-LEVODOPA 59 59 131 116
TRICOR 59 47 131 138
MEGACE ES 58 58 R 133 382
ALCOHOL SWABS 58 58 133 319
QUINIDINE GLUCONATE 56 51 10 135 712
FLUTICASONE PROPIONATE 56 52 135 26
FLUOXETINE HCL 55 49 137 63
EFFIENT 55 48 137 261
HUMULIN R 55 43 137 209
PROAIR HFA 55 51 137 32
RAPAFLO 55 55 137 246
LOVASTATIN 53 44 142 15
NAPROXEN 53 49 142 88
PRAVASTATIN SODIUM 52 47 144 20
FLECTOR 51 46 145 230
INDOMETHACIN 50 49 R 146 393
DETROL LA 50 49 146 260
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.